Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Synapse Biomedical Inc.
WARNING LETTER
•Synapse Biomedical Inc.•March 18, 2008

Synapse Biomedical Inc. – FDA Warning Letter, Mar 18, 2008

Record Details

This Warning Letter to Synapse Biomedical Inc. details objectionable conditions observed during an FDA inspection from February 25 to March 18, 2008, concerning their clinical studies for the [redacted] device. The inspection aimed to ensure compliance with federal regulations, scientific validity of data, and protection of human subjects.

Serious violations of 21 CFR Part 812—Investigational Device Exemptions were identified. Key violations include: 1. **Failure to obtain FDA approval prior to allowing subjects to participate (21 CFR 812.42):** Synapse Biomedical Inc. began an investigation by enrolling subjects and expanding to four additional clinical sites without prior FDA approval. Their response was inadequate, lacking a corrective and preventive action plan. 2. **Failure to ensure adequate monitoring of the investigation (21 CFR 812.40):** Monitoring was inadequate and not in accordance with their SOP. Examples include missing documentation for monitoring of 16 subjects, uncorrected omissions in monitoring visit reports (e.g., missing lab tests, discrepancies in data), and incorrect IDE numbers in reports. The company's response was incomplete, lacking documentation of SOP implementation or training, and a plan for verifying historical data. The monitoring SOP also failed to address protocol deviations. 3. **Failure to obtain signed financial disclosure agreements from investigators (21 CFR 812.43(c)(5)):**

Company
Synapse Biomedical Inc.
Inspection date
March 18, 2008
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Timothy A. Ulatowski (Director)
  • Moustapha Diop
View Company Profile

ID · ac438497-e30c-45c6-9720-9dbb0f5caed1

Violation Codes4
21 CFR 812.4221 CFR 812.4021 CFR 812.43(c)(5)21 CFR 812.43(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Synapse Biomedical Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.